Neal Walker - INTERIM CEO, Director at Aclaris Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
INTERIM CEO, Director
Stock Symbol
ACRS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Neal Walker since 12/23/2023

Holdings reported by Neal Walker for Aclaris Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.43M $5.39M $3.76 Dec 4, 2024 Direct
Restricted Stock Units 47.3K $107K $2.25 Dec 1, 2024 Direct Common Stock
Stock Option (Right to Buy) 497K Feb 1, 2024 Direct Common Stock
Employee Stock Option (right to buy) 0 Dec 4, 2024 Direct Common Stock

Transactions reported by Neal Walker for Aclaris Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.